Compact Microfluidic Device for Quick HbA1c Diabetes Testing
A Microfluidic Device for Detection of Glycated Haemoglobin
Tags: CSIR Labs, India, Healthcare & Lifesciences
CSIR-Central Scientific Instruments Organisation [CSIR-CSIO]: This technology is a microfluidic device designed for the detection of glycated haemoglobin (HbA1c) from whole blood samples. The device includes multiple chambers for blood processing, lysis, incubation, and simultaneous detection of both glycated hemoglobin and total hemoglobin. It offers a compact and efficient solution for monitoring diabetes by providing accurate HbA1c levels, which are crucial for long-term glucose control. The device's design facilitates rapid and precise analysis, making it suitable for point-of-care testing and clinical diagnostics.
IP Type or Form Factor: Patent Pending; Design; Device
TRL: Not specified
Industry or Tech Area: Diagnostics & Screening; Medical Devices
